|
|
|
|
Antithrombotics Market Forecast - New Market Report Published
New report provides detailed analysis of the Healthcare and Medical market Published on March 19, 2010by Press Office(Companiesandmarkets.com and OfficialWire)LONDON, ENGLAND IntroductionThe antithrombotics market, comprising anticoagulant and antiplatelet...
|
|
|
FDA Recommends Genetic Testing For Plavix, Opens Window For Effient
Remember Me Already a subscriber?Sign in or register to create an account? Search Include Synonyms PUBLICATIONS: Check All | Uncheck All 'The Pink Sheet' 'The Rose Sheet' Pharmaceutical Approvals Monthly 'The Gold Sheet' 'The Gray Sheet' Health News Daily ...
|
|
|
Chattem eyes 'smash' drug launch
Add a Comment iPod friendly version Text Size: A A A A Share/Bookmark This Page Zan Guerry - Download MP3 - Chattem will go head-to-head against some of the biggest health and beauty industry giants in America when it launches allergy drug Allegra, its chief...
|
|
|
FDA: Some Can't Process Plavix
The Food and Drug Administration is adding its strongest warning to the label for Plavix after reports that some patients cannot process the blockbuster blood thinner.The FDA said in a statement Friday that certain patients with a genetic variation...
|
|
|
FDA warning: some patients cannot process Plavix
WASHINGTON (AP) - The Food and Drug Administration is adding its strongest warning to the label for Plavix, cautioning that some patients do not respond to the blockbuster blood thinner.The FDA said in a statement Friday that certain patients with a...
|
|
|
FDA 'Black Box' Warning on Blood Thinner Plavix
The Food and Drug Administration (FDA) announced a boxed warning to the anti-blood clotting drug Plavix (clopidogrel), alerting patients and health care professionals that the drug can be less effective in people who cannot metabolize the drug to convert...
|
|
|
AIM: New study refutes FDA's contraindication for Plavix and PPIs
Heart patients who took proton-pump inhibitors (PPIs) along with clopidogrel were only half as likely to be hospitalized for upper digestive tract bleeding than those who used clopidogrel alone.In addition, the PPIs did not inhibit clopidogrels therapeutic...
|
|
|
Aging Committee raps pharma on brand drug price hikes
Armed with AARP and Kaiser Family research, members of the Senate Special Committee on Aging asked panelists why brand drug prices in the US continue to increase, while other countries pay half as much for the same products.The hearing, led by guest chair Sen....
|
|
|
AHRQ pump clots
BC-AHRQ-pump-clots To: NATIONAL EDITORS Contact: AHRQ Public Affairs, +1-301-427-1539, or +1-301-427-1998 ROCKVILLE, Md., March 15 /PRNewswire-USNewswire/ -- Heart patients who took a stomach acid-suppressing proton-pump inhibitor along with clopidogrel - a...
|
|
|
Week Of March 15, 2010: Company And People Notes: Abbott Agrees to Acquire Facet Biotech; FDA Issues Black-Box Warning For Plavix; and More.
_ Week Of March 15, 2010: Company And People Notes: Abbott Agrees to Acquire Facet Biotech; FDA Issues Black-Box Warning For Plavix; and More..
|
|
|
Week Of March 15, 2010: Company And People Notes: Abbott Agrees to Acquire Facet Biotech; FDA Issues Black-Box Warning For Plavix; and More.
_ Week Of March 15, 2010: Company And People Notes: Abbott Agrees to Acquire Facet Biotech; FDA Issues Black-Box Warning For Plavix; and More..
|
|
|
Week Of March 15, 2010: Company And People Notes: Abbott Agrees to Acquire Facet Biotech; FDA Issues Black-Box Warning For Plavix; and More.
_ Week Of March 15, 2010: Company And People Notes: Abbott Agrees to Acquire Facet Biotech; FDA Issues Black-Box Warning For Plavix; and More..
|
|
|
Plavix (clopidogrel): Reduced effectiveness in patients who are poor metabolizers of the drug
_ Plavix (clopidogrel): Reduced effectiveness in patients who are poor metabolizers of the drug.
|
|
|
Newer Blood Thinner Beats Plavix for Bypass Patients
TUESDAY, March 16 (HealthDay News) -- In a trial comparing two anti-clotting drugs, patients given Brilinta before cardiac bypass surgery were less likely to die than those given Plavix, researchers found.Both drugs prevent platelets from clumping and...
|
|
|
A Black-Box Warning for Plavix. Confusion May Follow
Health Blog HOME PAGE Share: Text Size The FDA says it added its strongest warning today to the label of the widely used bloodthinner Plavix, Bristol-Myers' best-selling drug, to help physicians treat patients correctly.But the warning could make...
|
|
|
Warning: Not All Boxed Warnings Are Equal
Boxed warnings on a drug's label don't carry skulls and crossbones, but they can sometimes be a death sentence in the revenue department.The Food and Drug Administration reserves the box for only the most severe warnings, which are often life-threatening...
|
|
|
FDA Adds Boxed Warning to Clopidogrel
Tests Available to Identify Patients Who Can't Metabolize Drug The FDA has added a boxed warning to the label for clopidogrel, the anti-blood clotting medication marketed as Plavix, because some patients do not effectively metabolize the drug and may not...
|
|
|
Week Of March 15, 2010: Company And People Notes: Abbott Agrees to Acquire Facet Biotech; FDA Issues Black-Box Warning For Plavix; and More.
_ Week Of March 15, 2010: Company And People Notes: Abbott Agrees to Acquire Facet Biotech; FDA Issues Black-Box Warning For Plavix; and More..
|
|
|
FDA adds boxed warning to clopidogrel
The FDA has added a boxed warning to clopidogrel (Plavix; Sanofi Aventis, Bristol Myers Squibb).The new warning is for patients who do not effectively metabolize the drug anywhere from 2% to 14% of the population. Although a warning about this...
|
|
|
Biogel adds two new surgical gloves with improved grip to non-latex polyisoprene line
Patients who take a proton-pump inhibitor with medicine to prevent blood clots are less likely to be hospitalized for bleeding ulcers Heart patients who took a stomach acid-suppressing proton-pump inhibitor along with clopidogrela drug that prevents blood...
|
|
|
GHX launches Procurement Suite spend management solution for hospitals
Patients who take a proton-pump inhibitor with medicine to prevent blood clots are less likely to be hospitalized for bleeding ulcers Heart patients who took a stomach acid-suppressing proton-pump inhibitor along with clopidogrela drug that prevents blood...
|
|
|
Cancer costs more than doubled in 40-year fight
Patients who take a proton-pump inhibitor with medicine to prevent blood clots are less likely to be hospitalized for bleeding ulcers Heart patients who took a stomach acid-suppressing proton-pump inhibitor along with clopidogrela drug that prevents blood...
|
|
|
Atul Gawande, MD, speaks out for checklists in the OR at AORN
Patients who take a proton-pump inhibitor with medicine to prevent blood clots are less likely to be hospitalized for bleeding ulcers Heart patients who took a stomach acid-suppressing proton-pump inhibitor along with clopidogrela drug that prevents blood...
|
|
|
Patients who take a proton-pump inhibitor with medicine to prevent blood clots are less likely to be hospitalized for bleeding ulcers
Heart patients who took a stomach acid-suppressing proton-pump inhibitor along with clopidogrela drug that prevents blood clotswere only half as likely to be hospitalized for upper digestive tract bleeding than those who used clopidogrel alone, according to a...
|
|
|
Forensic role of bacteria?
Patients who take a proton-pump inhibitor with medicine to prevent blood clots are less likely to be hospitalized for bleeding ulcers Heart patients who took a stomach acid-suppressing proton-pump inhibitor along with clopidogrela drug that prevents blood...
|
